et al.. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. ABSTRACT The antioxidant N-acetyl-L-cysteine (NAC) had been shown to inhibit replication of seasonal human influenza A viruses. Here, the effects of NAC on virus replication, virusinduced pro-inflammatory responses and virus-induced apoptosis were investigated in H5N1-infected lung epithelial (A549) cells. NAC at concentrations ranging from 5 to 15 mM reduced H5N1-induced cytopathogenic effects (CPE), virus-induced apoptosis and infectious viral yields 24 hours post-infection. NAC also decreased the production of proinflammatory molecules (CXCL8, CXCL10, CCL5, interleukin-6 (IL-6)) in H5N1-infected A549 cells and reduced monocyte migration towards supernatants of H5N1-infected A549 cells. The antiviral and anti-inflammatory mechanisms of NAC included inhibition of activation of oxidant sensitive pathways including transcription factor NF-қB and mitogen activated protein kinase p38. Pharmacological inhibitors of NF-қB (BAY 11-7085) or p38 (SB203580) exerted similar effects like those determined for NAC in H5N1-infected cells.
Introduction
Highly pathogenic H5N1 influenza A viruses are considered to be potential progenitors of a novel influenza pandemic [1] [2] [3] [4] [5] [6] . Human infections with highly pathogenic influenza A H5N1 viruses are associated with severe pneumonia, lymphopenia, high viral loads in the respiratory tract, and hyper-induction of cytokines and chemokines (cytokine storm) [7] . Pathological investigations revealed that induction of apoptosis may be a major mechanism in the destruction of alveolar epithelial cells in humans infected with H5N1 [8] .
Apoptosis may be a direct consequence of virus replication as well as result from excessive inflammatory responses to virus infection [6] .
Production of reactive oxygen species (ROS) has been shown to contribute to pulmonary damage caused by influenza virus infection [9] [10] [11] . Recently, ROS were suggested to contribute to acute lung injury in people with severe influenza A virus infection by triggering the signalling of oxidised phospholipids through toll-like receptor 4 (TLR4)-TIR-domain-containing adaptor-inducing interferon-(TRIF)-TNF receptor associated factor 6 (TRAF6) cascade [12, 13] . Different sources of ROS have been suggested in influenza A virus-infected lungs. Leukocytes may be activated and primed by influenza A virus infection and produce ROS [14] . Moreover, increased xanthine oxidase levels were found in influenza A virus-infected lungs [14] . Epithelial cells of the lungs may also be a source of ROS since influenza A virus infection induced oxidant stress response in cultured airway epithelial [15, 16] .
Endogenous oxidants may be involved in signal transduction pathways that stimulate production of cytokines/chemokines through activation of transcription factors and induction of pro-inflammatory gene expression in influenza A-infected cells [16] .
Influenza A viruses including H5N1 strains were shown to induce expression of cytokines and chemokines, including CXCL8 (also known as interleukin-8), interleukin-6 (IL-6), 4 CXCL10 (also known as interferon-inducible cytokine IP-10), and CCL5 (also known as RANTES) in macrophages and airway epithelial cells through oxidant sensitive pathways such as mitogen activated kinase p38 and the transcription factor nuclear factor-B (NF-B) [2, [17] [18] [19] .
Antioxidant molecules including reduced glutathione and its precursor N-acetyl-Lcysteine (NAC) are potentially useful against infection with influenza A viruses [20] [21] [22] [23] .
Notably, NAC was already shown to synergise with oseltamivir in the treatment of lethal seasonal influenza A virus infection in a mouse model [23] . Here, we investigated the effects of NAC as prototype antioxidant on virus replication, virus-induced apoptosis, and expression of pro-inflammatory molecules in A549 cells infected with human H5N1 influenza A virus. Moreover, the influence of NAC on NF-B and p38, both constituents of cellular signalling pathways known to be of relevance for influenza A virus replication, was studied in H5N1-infected cells.
Material and methods

Virus stock
The H5N1 Influenza A strain A/Thailand/1(Kan-1)/04 was obtained from Prof. Pilaipan
Puthavathana (Mahidol University, Bangkok). The H5N1 Influenza A strain A/Vietnam/1203/04 was received from the WHO Influenza Centre at the National Institute for Medical Research London (Great Britain). Virus stock were prepared by infecting Vero cells (African green monkey kidney; ATCC: CCL81, Manassas, VA, USA) and aliquots were stored at -80°C. Virus titres were determined as 50% tissue culture infectious dose (TCID 50 /ml) in confluent cells in 96-well microtiter plates (Greiner Bio-One, Frickenhausen, Germany).
Cells
A549 cells (human lung carcinoma; ATCC: CCL-185, Manassas, VA, USA) and Vero cells were grown at 37°C in minimal essential medium (MEM, Biochrom AG, Berlin, Germany) supplemented with 10% foetal bovine serum (FBS, Sigma-Aldrich Chemie GmbH, Munich, Germany), 100 IU/ml penicillin (Grünethal GmbH, Aachen, Germany) and 100µg/ml streptomycin (Sigma-Aldrich Chemie GmbH, Munich, Germany).
Drugs
N-acetyl-L-cysteine (NAC) was obtained from Alexis (distributed by Axxora, Germany), dissolved in unsupplemented MEM and adjusted to pH 7.4 with NaOH. The caspase-3
inhibitor Ac-DEVD-CHO, the NF-inhibitor BAY 11-7085 and the p38 MAP kinase inhibitor SB 203580 were obtained from Merck Biosciences (Darmstadt, Germany).
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Cell viability assay
Confluent A549 cells were treated with NAC for 48 h. The cellular viability was assessed with CellTiter-Glo ® Luminescent Cell Viability Assay (Promega GmbH, Mannheim, Germany) according to the manufacturers' protocol. Cell viability was expressed as percentage of non-treated control.
Cytopathogenic effect (CPE) reduction assay
Confluent A549 cell layers were infected with influenza A (H5N1) at an MOI of 0.01 in MEM supplemented with 2% FBS, 100 IU/ml penicillin and 100µg/ml streptomycin. Cells were continuously treated with NAC starting with a 24 h pre-incubation period prior to infection. 24 h post-infection (p.i.) the virus induced CPE was recorded using an inverted light microscope (Olympus, Planegg, Germany).
Virus yield reduction assay
Confluent A549 cell layers were infected with influenza A (H5N1) at an MOI of 0.01 in MEM supplemented with 2% FBS, 100 IU/ml penicillin and 100µg/ml streptomycin. Cells were continuously treated with NAC starting with a 24 h pre-incubation period prior to infection. At the given time points, aliquots of the supernatants were taken and serial 10fold dilution steps were performed. Infectivity was determined by endpoint dilution titration onto Vero cells in 96-well microtiter plates. Plates were incubated for 3 to 4 days and infectivity was analysed by virus-induced cytopathic effect. Virus titres were calculated by the method of Reed and Muench [24] .
Indirect immunofluorescence microscopy
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Migration assay
Cell culture supernatants were investigated for chemotactic activity by measurement of the activity to induce monocyte migration through membrane inserts in 24-well plates (pore and cell culture supernatants (300µl) were added to the lower chamber of the well. After a 48 h incubation period, cells were fixed with 4% paraformaldehyde and permeabilised with PBS containing 0.3% Tritron X-100. Then, nuclei were stained with DAPI. The upper side of the membrane was wiped with a wet swab to remove the cells, while the lower side of the membrane was rinsed with PBS. The number of cells at the lower side of each membrane was quantified by counting of cells from three randomly chosen sections (3.7 mm 2 ) using a Olympus IX 1 fluorescence microscope.
Cytokine/Chemokine secretion
Cell culture supernatants were collected and frozen at -80°C. Cytokines/Chemokines were quantified by specific ELISA Duo Sets (R&D Systems GmbH, Wiesbaden, Germany)
following the manufacturer's instructions.
NF-қB activity
NF-қB activity was investigated by quantification of the NF-қB subunits Rel A (p65) and NF-қB1 (p50) from nuclear extracts using the NF-қB Transcription Factor assay kit (Active Motif, Rixensart, Belgium). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   9 England Biolabs GmbH, Frankfurt am Main, Germany) and were visualised by enhanced chemiluminescence using a commercially available kit (Amersham, Freiburg, Germany).
Western blot analysis
Caspase activity
Cells were tested for caspase activity (expressed as relative luminescence units (RLU)) using the Caspase-Glo ® 3/7, -8, and 9 Assay kit (Promega GmbH, Mannheim, Germany)
following the manufacturer's instructions. Luminescence was measured using TECAN Infinite 200 (Tecan Deutschland GmbH, Crailsheim, Germany).
Statistical analysis
All data are given as the mean ± SD. Statistical analysis was performed using Statistical analysis of results was performed by Student t test. p values of <0.05 were considered statistically significant.
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Influence of NAC on H5N1 virus replication in A549 cells
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Influence of NAC on H5N1-induced caspase activation
ROS formation may result in caspase-dependent apoptosis and virus-induced apoptosis may be a major mechanism in the destruction of epithelial cells infected with H5N1 both in vitro and in vivo [8, 25] . To investigate the influence of NAC on H5N1-induced apoptosis in A549 cells, cells were treated with or without NAC and infected with H5N1 at an MOI of 0.01. 24 hours p.i., cells were analysed for caspase-8, -9 and -3/7 activity. H5N1
infection increased the caspase-8 (2.1-fold), caspase-9 (2.4-fold) and caspase-3/7 (7.7-fold) activity relative to the mock infected cells ( Fig. 2A, 2B Moreover, inhibition of caspase 3 resulted in retention of influenza virus ribonucleoprotein (RNP) complexes in the nucleus of infected cells and in turn to inhibition of influenza A virus replication [26] . To investigate the influence of NAC on retention of RNP complexes, A549 cells were treated with or without 15 mM NAC or caspase 3 inhibitor and infected with H5N1 (MOI 0.1). Eight hours p.i., cells were analysed for RNP export.
Similar to the caspase 3 inhibitor that served as positive control, NAC inhibited nuclear export of the viral RNP as indicated by immunofluorescence staining (Fig. 3 ).
Influence of NAC on cytokine and chemokine production in H5N1-infected cells
Virus-induced cytokine/chemokine storm seems to contribute to severe pathogenesis of H5N1 infection in humans [6] . In addition to investigation of virus inhibitory effects, the influence of NAC on the production of cytokines/chemokines which had been correlated to progression of H5N1 disease was studied. Supernatants from mock-or H5N1-infected cultures were compared for expression of CCL5, IL-8, CXCL10 and IL-6 by ELISA ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 reduce the CXCL-10 and IL-6 secretion to levels of untreated cells (mock) whereas the production of CXCL-8 or CCL-5 was significantly decreased in comparison to untreated H5N1-infected cells (1.7-fold or 6.0-fold reduction, respectively) but clearly remained higher than the mock levels ( Fig. 4 ).
Influence of NAC on chemoattraction of monocytes by supernatants from H5N1infected A549 cells
H5N1 infection is characterised by massive infiltration of monocytes/macrophages into the lungs in humans [6] . The potential to attract immune cells including monocytes is a criterion for pro-inflammatory potential of (virus-infected) cells. Migration assays using supernatants from NAC-treated or -untreated uninfected or H5N1-infected (MOI 0.01) A549 cells to attract monocytes were performed. The number of migrated monocytes was 5 times higher towards supernatants of H5N1-infected cells than towards supernatants of uninfected cells (Fig. 5 ). NAC 15 mM treatment reduced monocyte migration towards supernatants of infected cells (3.1-fold decrease relative to virus control) ( Fig. 5 ) but did not significantly affect migration of monocytes towards supernatants of mock-infected cells (data not shown).
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Influence of NAC on activation of redox sensitive cellular signalling pathways relevant in influenza pathology
NF-қB and p38 are commonly activated in response to oxidative stress and known to be of relevance for influenza A virus replication and pathology [27] [28] [29] . NAC was shown to inhibit both H5N1-induced p38 and NF-қB activation (Fig. 6 ). NAC 15 mM inhibited H5N1-induced p38 phosphorylation as indicated by Western blot (Fig. 6A ). Detection of induction of the NF-қB subunits Rel A (p65) and NF-қB1 (p50) in A549 nuclear cell extracts using a subunit specific NF-қB binding ELISA kit revealed that NAC inhibited H5N1-induced NF-қB activation (Fig. 6B ). In untreated H5N1-infected A549 cells nuclear levels of p65 and p50 resulted in relative luminescence units (RLU) of 3.8x10 6 ± 1.1x10 5 RLU and 6.7x10 6 ± 1.9x10 5 RLU, respectively. In NAC 15 mM-treated H5N1-infected cells nuclear levels of p65 and p50 correlated to 2.4x10 6 ± 1.6x10 5 RLU and 4.1x10 6 ± 4.4x10 5 RLU, respectively.
Influence of specific pharmacological inhibitors of p38 or NF-қB on H5N1 replication in A549 cells
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Discussion
In the present paper, we demonstrate that NAC treatment inhibited H5N1 influenza A virus replication and H5N1-induced cell death. Moreover, NAC diminished H5N1induced expression of the cytokines/chemokines CCL5, CXCL8, CXCL10 and IL-6 and migration of monocytes towards supernatants of H5N1-infected cells. NAC is an effective antioxidant. It enriches the intracellular sulfhydryl pool, acting as a precursor of reduced glutathione (GSH) [20] . Protective activity of NAC against seasonal influenza A infection was shown in animal studies by decreasing mortality of mice infected with the influenza A strain A/PR/8 (H1N1) [30] . In humans, NAC significantly reduced the incidence of clinically apparent A/H1N1 disease [20] . In cell culture experiments NAC prevented influenza A (H3N2) virus-induced oxidative stress, cell death, expression of inflammatory genes and NF-B activity [16, 31] .
It is probable that NAC antiviral activity against H5N1 virus results from its ability to inhibit activation of intracellular signalling molecules and transcription factors which are sensitive to oxidants produced during influenza A infection. In concordance, NAC treatment reduced formation of ROS in H5N1-infected cells [ Figure S1 , available as
Supplementary data] as well as prevented activation of two constituents of redox-sensitive signalling pathways: 1) transcription factor NF-B and 2) MAPK p38. Both signalling pathways are known to be involved in influenza A virus pathogenesis [28, 29, 32] .
Numerous substances that cause inhibition of NF-B including the radical scavenger pyrrolidine dithiocarbamate (PDTC), the proteasome inhibitor MG132, the cyclooxygenase (COX) inhibitor acetylsalicylic acid and the specific NF-B inhibitor BAY11-7085 were shown to inhibit influenza A virus replication [33] [34] [35] . Similar to other NF-B inhibitors, NAC concentrations required to block viral replication directly correlated with the 16 concentration needed to inhibit NF-B. Moreover, the NF-B inhibitor BAY11-7085 was also able to inhibit H5N1 replication in our setting.
NF-B activation may result in inhibition or promotion of apoptosis depending on
the cell type and the context [36] . NAC had already been shown to increase apoptosis in hypoxic cells through inhibition of NF-B [37] . However, NAC had previously also been demonstrated to concomitantly impair influenza A (H3N2) virus-induced NF-B activity and cell death [16] . Moreover, recent results demonstrated that different NF-B inhibitors suppress apoptosis in H5N1-infected A549 cells [33] . Therefore, inhibition of H5N1 infection activates p38 in A549 cells. p38 inhibition did not influence virus replication in macrophages or chorion cells cells infected with H1N1 or H5N1 virus strains in some previous reports [28, 34, 39, 40] . In MDCK cells, however, the pharmacological p38 inhibitor SB203580 was shown to inhibit RNP transport from the nucleus to the cytosol [32] . Since nuclear export of the RNP complex has been shown to be a critical step in influenza A virus replication this suggests that p38 inhibition may affect H5N1 replication in certain cell types [33] . In our model, the p38 inhibitor SB203580 inhibited H5N1
replication indicating that p38 activation may play a role for H5N1 replication in epithelial cells. The combination of the NF-B inhibitor BAY11-7085 and the p38 inhibitor SB203580 caused increased inhibition of H5N1 replication compared to either single treatment. Although differences did not achieve statistical significance this further supports that NAC-induced inhibition of both pathways may contribute to the anti-H5N1 effects exerted by NAC. Notably, NAC had been reported to impair RANTES expression without affecting p38 phosphorylation in H1N1-infected bronchial epithelial cells (cell line NCI-H292) [31] . These varying findings further stress that drug effects may depend on the context and differ between different cells as well as between different viruses.
The mechanism of NAC-induced suppression of chemokine/cytokine production in H5N1-infected cells appears to also involve inhibition of activation of p38 and NF-B. The p38 inhibitor SB203580 as well as the NF-B inhibitor BAY 11-7085 both reduced production of pro-inflammatory cytokines/chemokines in H5N1-infected cells.
Combination of both substances resulted in a significantly increased suppression of production of pro-inflammatory molecules. Notably, NAC also inhibited H5N1-induced 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 18 Both pathways have already been suggested to be involved in H5N1-induced proinflammatory signalling. In human primary macrophages, H5N1 and H1N1 viruses did not differ in the activation of NF-B but unlike H1N1 virus, H5N1 viruses strongly activated p38 resulting in production of inflammatory cytokines and chemokines [28, 39] . Similarly to these experiments with human macrophages, the treatment of A549 cells with SB203580 specific p38 inhibitor described here significantly suppressed expression of inflammatory cytokines/chemokines. In a transgenic mouse model with a deletion of p50 NF-B subunit, H5N1 virus infection resulted in a lack of hypercytokinemia [41] .
However, H5N1 pathogenesis was not altered in this model [41] . Moreover, cytokine and chemokine knockout mice or steroid-treated wild-type mice did not have survival advantage over wild-type mice after viral challenge [42] . These data indicate that suppression of cytokine/chemokine expression alone is not sufficient to improve disease outcome. However, control of excessive inflammation may have beneficial effects in combination with antiviral treatment that reduces virus loads. Indeed, delayed antiviral treatment with neuraminidase inhibitors in combination with immunomodulatory substances reduced mortality in mice infected by high inoculums of H5N1 virus [43] . In these experiments, significant improvements in survival rate, survival time, and inflammatory markers were reported for mice treated with a triple therapy containing zanamivir and immunomodulators including celecoxib, and mesalazine in comparison to zanamivir alone. Zanamivir with or without immunomodulators reduced viral load to a similar extent [43] . Therefore, antioxidants like NAC may serve as additional therapeutic options affecting in parallel H5N1 replication as well as H5N1-induced expression of proinflammatory molecules. Although NAC concentrations which showed antiviral and antiinflammatory effects in H5N1 infected cells are unlikely to be achieved in humans by oral administration, NAC administered by alternative routes (inhalation, parental) may result in therapeutically effective concentrations.
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Material and methods
Examination of intracellular ROS in A549 cells
ROS levels were analysed using Image-iT TM Live Green Reactive Oxygen Species Detection Kit (Invitrogen GmbH, Karlsruhe, Germany) according to the manufacturers' protocol. H5N1
or MOCK infected A549 cells pre-treated with or without 15mM NAC were rinsed three times with PBS and incubated with PBS containing 25µM carboxy-H 2 DCFDA at 37°C for 30min. After washing with PBS, cells were analysed using fluorescence microscope.
Cytokine/Chemokine secretion and Caspase activity in monocytes-derived macrophages
Monocytes were isolated as described in material and methods (2.8 Isolation of human monocytes). For differentiation, cell culture medium (10% pooled human serum, 100 IU/ml of penicillin and 100µg/ml streptomycin) was supplemented with 500 IU/ml recombinant human GM-CSF from PeproTech (distributed by Cell Concepts GmbH, Umkirch, Germany). Every second day a medium change was performed. After 14 days monocytes derived macrophages were infected with A/Thailand/1(Kan-1)/04 at an MOI of 2 and treated with NAC at concentrations ranging from 5 to 15 mM. Cells were continuously treated with NAC starting with a 24 h pre-incubation period prior to infection. 24 hours post-infection (p.i.) supernatants were collected and analysed for cytokine/chemokine expression as described in material and methods (2.10 Cytokine/Chemokine secretion) and cells were tested for caspase 3/7 activity as described in material and methods (2.13 Caspase activity).
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